New eczema cream shows promise in early trial
NCT ID NCT06891040
First seen Apr 22, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tested a cream called VC005 in 118 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if it reduces skin redness, itching, and rash better than a cream with no active ingredient. Researchers measured changes in the Eczema Area and Severity Index (EASI) from the start of the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese Academy of Medical Sciences Hospital of Skin Disease
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.